Autism, Common Digestive System Pathogens, and Microbiome Imbalance
Microbiota transfer therapy (MTT) and its effectiveness in autism
This past month I had the pleasure of interviewing James Adams, PhD from Arizona State University (ASU) on my Functional Medicine Doc Talk podcast. The topic was digestive system problems in autism, including the existence of various pathogens (e.g., Clostridium difficile), and the benefits of Microbiota Transfer Therapy (MTT), aka fecal transplant (Its important to understand there are some differences between MTT and traditional fecal transplant).
Dr. Adams has conducted a number of trials for MTT in autism, written two clinically relevant research articles on this topic, and is highly published in other areas as well.
He is the Director of the Autism/Asperger’s Research Program at ASU, and is involved in other non-profit autism-related organizations.
James B. Adams, Ph.D., is the Director of the Autism/Asperger’s Research Program at Arizona State University. His research focuses on the medical causes of autism and how to treat and prevent it including the areas of nutrition (vitamins/minerals, essential fatty acids, carnitine, digestive enzymes, special diets), oxidative stress, gut bacteria, microbiota transplant, probiotics, toxic metals, and seizures. He has extensively researched prenatal supplements to reduce the risk of pregnancy complications and infant health problems, and has developed the first prenatal supplement tailored for each trimester. He has published over 180 peer-reviewed scientific articles, including over 60 related to autism. He is the President of the non-profit Autism Nutrition Research Center, President of Autism Diagnostics, President of Gut-Brain-Axis Therapeutics, and chair of the Scientific Advisory Board of the Neurological Health Foundation. He received the Presidential Young Investigator Award from President George Bush. He has an adult daughter with autism.